Business:
Biologics
Drug notes:
RZ402 Clin2 diabetic macular edema
About:
Rezolute is developing drug therapies to cure patients with metabolic diseases associated with chronic glucose imbalance. Both extreme low (hypoglycaemia) and high (hyperglycaemia) blood glucose levels cause disease. Rezolute is developing antibody-based therapies to treat patients with congenital hyperinsulinism (HI), diabetic macular edema and tumor HI. Their approach is to leverage their metabolic expertise to define disease pathways and create therapies that overcome the shortcomings of current standards of care. Rezolute’s lead program, RZ358, is in late-stage clinical trials for congenital HI.
Senior Clinical Trial Manager Redwood City|7 days ago
Executive Director, Channel Strategy & Patient... Redwood City Remote|7 days ago
National Field Director (Executive Director) Redwood City Remote|7 days ago
Associate Director, Quality Control Redwood City Remote|7 days ago
Sr. Program Manager Redwood City Bend|11 days ago
Executive Director - Commercial Operations Redwood City|19 days ago
Executive Director, Marketing Redwood City|19 days ago
Director, Human Resources Redwood City|29 days ago
Vice President, Legal Affairs Redwood City|29 days ago
Director of Medical & Patient Affairs Operatio... Redwood City|40 days ago